no systematic search by-topic.
12845623 2003. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
12928031 2003. Coronavirus in severe acute respiratory syndrome (SARS).
14743497 2004. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in?situ hybridization study of fatal cases
15127935 2003. Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus
15141376 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS?CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
15306390 2004. Viral evolution and the emergence of SARS coronavirus
15326590 2004. Human SARS-coronavirus RNA-dependent RNA polymerase: activity determinants and nucleoside analogue inhibitors.
15381196 2004. Cellular entry of the SARS coronavirus
15527829 2004. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.
15631713 2004. A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children
15690493 2004. Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding.
15705339 2005. SARS clinical features, United States, 2003.
15833113 2005. Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies
15858003 2005. Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E.
16211163 2005. Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling.
16358325 2006. Binding site-based classification of coronaviral papain-like proteases.
16600962 2006. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
16678878 2006. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
16690096 2006. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients
17079315 2007. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.
17083088 2007. Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme.
17142081 2007. Molecular pathogenesis of severe acute respiratory syndrome
17397959 2008. SARS coronavirus replicase proteins in pathogenesis.
17766393 2007. Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein.
19319935 2009. C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer.
21922588 2011. SARS-CoV heptad repeat 2 is a trimer of parallel helices.
24995382 2014. Accessory proteins of SARS-CoV and other coronaviruses
31668196 2019. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features.
32402576 ä. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection
C7149537 2008. (mech resp)Severe Acute Respiratory Syndrome (SARS)
| 17031779 2006. Expression of elevated levels of pro?inflammatory cytokines in SARS?CoV?infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS?
|
| 23607598 2013. Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome
|
